IRIS - Res&Arch Institutional Research Information System - Research & Archive

RUGGERI, Loredana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.210
EU - Europa 1.770
AS - Asia 744
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
SA - Sud America 1
Totale 4.730
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.209
IE - Irlanda 430
UA - Ucraina 312
IT - Italia 300
SG - Singapore 283
SE - Svezia 278
HK - Hong Kong 208
CN - Cina 137
FI - Finlandia 128
DE - Germania 82
RU - Federazione Russa 82
VN - Vietnam 59
GB - Regno Unito 51
FR - Francia 22
KR - Corea 17
BE - Belgio 15
CH - Svizzera 11
TR - Turchia 11
NL - Olanda 10
RO - Romania 10
CZ - Repubblica Ceca 9
GR - Grecia 8
IN - India 8
AT - Austria 7
LB - Libano 7
PL - Polonia 6
UZ - Uzbekistan 4
BG - Bulgaria 2
EU - Europa 2
LT - Lituania 2
LV - Lettonia 2
SA - Arabia Saudita 2
TW - Taiwan 2
AU - Australia 1
AZ - Azerbaigian 1
CA - Canada 1
EE - Estonia 1
ES - Italia 1
GE - Georgia 1
IL - Israele 1
JO - Giordania 1
MA - Marocco 1
PE - Perù 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
ZA - Sudafrica 1
Totale 4.730
Salva come PNG Salva come JPEG
Città #
Chandler 443
Dublin 430
San Mateo 287
Singapore 238
Hong Kong 207
Boardman 156
Jacksonville 150
Perugia 118
Santa Clara 99
Medford 82
Princeton 82
Altamura 71
Ann Arbor 70
Wilmington 64
Andover 63
Dong Ket 59
Lawrence 55
Beijing 48
Helsinki 38
Des Moines 30
Saint Petersburg 24
Woodbridge 21
Norwalk 20
Ashburn 18
Munich 17
Redwood City 17
Los Angeles 15
Shanghai 15
Espoo 13
Foligno 13
San Paolo di Civitate 13
Houston 12
Seoul 12
Brussels 11
Izmir 10
Dallas 9
Moscow 9
New York 9
Redmond 8
Bucharest 7
Brno 6
Chicago 6
Ancona 5
Auburn Hills 5
Den Haag 5
Falls Church 5
Florence 5
Rome 5
Dearborn 4
Deruta 4
Philadelphia 4
West Jordan 4
Zaventem 4
Amsterdam 3
Aurora 3
Mirano 3
Padova 3
Prata Di Pordenone 3
San Diego 3
Vienna 3
Bengaluru 2
Bologna 2
Bupyeong-gu 2
Chiajna 2
Eunpyeong-gu 2
Falkenstein 2
Groningen 2
Guangzhou 2
Nanning 2
Naples 2
Oklahoma City 2
Olomouc 2
Paris 2
Piscataway 2
Riga 2
Riyadh 2
Simi Valley 2
Stockholm 2
Taipei 2
Valenza 2
Zhengzhou 2
Ahmedabad 1
Athens 1
Atlanta 1
Baku 1
Bratislava 1
Castelnuovo Berardenga 1
Chengdu 1
Collazzone 1
Dong-gu 1
Dushanbe 1
Edinburgh 1
Gatchina 1
Göteborg 1
Hangzhou 1
Hanover 1
Hefei 1
Huizhou 1
Hyderabad 1
Issaquah 1
Totale 3.207
Salva come PNG Salva come JPEG
Nome #
Innate immunity against hematological malignancies 106
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells 98
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 93
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation 92
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. 83
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. 80
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 80
. G-CSF blocks IL-12 productin by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation. 79
G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation.. 77
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 72
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 72
Natural killer cells: biology and application in stem-cell transplantation 71
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 71
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 71
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 71
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 69
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 69
Haploidentical transplantation and natural killer cell recognition of missing self. 67
A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein function 67
Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease 66
Natural killer cell alloreactivity for leukemia therapy. 66
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 65
"Designed" grafts for HLA-haploidentical stem cell transplantation. 65
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 65
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT. 64
Cellular therapy: exploiting NK cell alloreactivity in transplantation 63
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 63
Preclinical characterization of 1-7F9,a novel human anti-KIR receptor therapeutic antibody that augments natural kille-mediated killing of tumor cells. 63
Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants 62
Clinical impact of natural killer cell reconstitution after allogenic hematopoitic transplantation.Immunobiology working Party of the European Group for Blood and Marrow Transplantation 62
Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. 61
Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation 61
Alloreactive natural killer cells for the treatment of acute myeloid leukemia: From stem cell transplantation to adoptive immunotherapy 60
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 60
Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation 60
Involvement of Cd44 Variant Isoforms In Hyaluronate Adhesion By Human Activated T-cells 59
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 57
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 56
CD44 signaling through p56lck involves lateral association with CD4 in human CD4+ T cells. 55
The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell–Depleted Hematopoietic Stem Cell Transplantation 55
Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation. 55
Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation 52
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 52
NCRs and DNAM-1 mediate NK cell recognition and iysis of human and mouse melanoma cell lines in vitro and in vivo 51
New mechanism of lymphoma-induced bone marrow aplasia 51
Natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation 50
Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer. 50
Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1. 49
Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation. 49
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 47
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants 47
Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. 47
Striking survival advange of bad-risk acute myeloid leukemia patients transplanted from haploidentical donors with KIR epitope incompatibility in the GVH direction 47
Transplantation for high-risk acute leukemia with high doses of T cell-depleted hematopoietic stem cells from haploidentical “three loci” incompatible donors. 46
Natural killer cell allorecognition of missing self in allogenic hematopoietic transplantation :a tool for immunotherapy of leukemia. 46
null 46
Identifying NK alloreactive donors for haploidentical hematopoietic stem cell transplantation 46
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients 46
Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation. 45
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 45
Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect 44
Jack of all trades: thymosin α1 and its pleiotropy. 44
The “ultimate” haploidentical transplantation for the elderly with high-risk acute myeloid leukemia 44
Post-grafting granulocyte colony-stimulating factor administration impairs functional immune recovery in recipients of HLA haplotype-mismatched hematopoietic transplants 42
Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells 42
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. 41
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 41
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. 41
Natural Killer (NK)-Cell Function and Anti-Leukemic Activity of a Large Population of CD3+/CD8+ T Cells Expressing NK Receptors for MHC Class I after “Three-Loci” HLA-Incompatible Bone Marrow Transplantation 40
NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation. 40
Natural killer-cell KIR repertoire reconstitution after haploidentical SCT. 40
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 39
Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant. 39
The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation. 39
Treatment of high-risk acute leukemia with T-cell-depleted stem cell related donors with one fully mismatched HLA haplotype. 38
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 38
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 37
NK cells: a lesson from mismatched hematopoietic transplantation 36
null 36
CD44 signaling through p56lck involves lateral association with CD4 in human CD4+ T cells 34
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 33
Next generation HLA-haploidentical HSCT 31
A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia 30
CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma 28
null 27
Natural killer cell-mediated lysis of autologous cells modified by gene therapy 26
Natural killer cells as a therapeutic tool in mismatched transplantation 26
Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies 25
Natural killer cell activity and killer immunoglobulin-like receptors in hematopoietic stem cell transplantation 25
Natural killer (NK)-cell function and antileukemic activity of a large population of CD3+/CD8+ T cells expressing NK receptors for major histocompatibility complex class I after "three-loci" HLA-incompatible bone marrow transplantation 24
Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia 22
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation 21
null 20
How adoptive transfer of components of the donor immune system boosts GvL and prevents GvHD in HLA-haploidentical hematopoietic transplantation for acute leukemia 18
Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax 17
null 11
Totale 4.922
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.803
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.803
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020218 0 0 0 0 0 6 47 7 65 37 16 40
2020/2021685 9 59 25 53 203 55 46 7 73 24 56 75
2021/2022873 14 235 29 51 45 5 6 231 10 36 101 110
2022/20231.394 91 258 15 108 97 150 4 67 524 8 53 19
2023/2024652 40 78 24 8 3 9 173 14 61 21 112 109
2024/2025541 23 136 34 89 199 60 0 0 0 0 0 0
Totale 4.922